In: Vaccines, 2021, vol. 9, no. 9, p. 7
Since marketing authorization, cases of neuralgic amyotrophy (NA), facial paralysis/Bell’s palsy (FP/BP), and Guillain-Barré syndrome (GBS) were reported with COVID-19 vaccines of different technologies. This study aimed to assess whether NA, FP/BP, and GBS were more frequently reported in VigiBase with COVID-19 vaccines (of any technologies) than with other viral vaccines, over the full...
|
In: Journal of Neurology, 2015, vol. 262, no. 4, p. 870-880
|
In: Journal of Neuro-Oncology, 2015, vol. 121, no. 2, p. 389-397
|
In: Annals of Surgical Oncology, 2014, vol. 21, no. 3, p. 915-921
|
In: Neurological Sciences, 2011, vol. 32, no. 1, p. 151-153
|
In: Pediatric Nephrology, 2013, vol. 28, no. 7, p. 1141-1144
|
In: Clinical & Experimental Metastasis, 2009, vol. 26, no. 7, p. 809-815
|
In: Journal of Gastrointestinal Surgery, 2009, vol. 13, no. 4, p. 581-586
|
In: Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, vol. 243, no. 3, p. 263-265
|
In: Journal of Neuro-Oncology, 2011, vol. 102, no. 2, p. 301-301
|